Non-Small Cell Lung Cancer New Reference: Zongertinib for her2 Mutated NSCLC Ulas D. Bayraktar, MD 2025-05-05
Mantle cell lymphoma New Reference: Acalabrutinib with R-Bendamustine in Untreated Mantle Cell Lymphoma Ulas D. Bayraktar, MD 2025-05-04
GastroEsophageal Cancer New Protocol: Atezolizumab and Trastuzumab with CapeOx for Periop Her2+ Gastric Cancer Ulas D. Bayraktar, MD 2025-05-04
Mesothelioma New Protocol: Atezolizumab with Carbo-Pem-Bev for Pleural Mesothelioma Ulas D. Bayraktar, MD 2025-05-04
Endocrine Cancer (Non-Thyroid) New Reference: Belzutifan for vHL Associated Tumors Ulas D. Bayraktar, MD 2025-05-04
Colorectal Cancer New Reference: Neoadjuvant Dostarlimab for dMMR Tumors Ulas D. Bayraktar, MD 2025-05-04
Non-Small Cell Lung Cancer New Indication: Nivolumab – Ipilimumab for Neoadjuvant NSCLC Ulas D. Bayraktar, MD 2025-04-22
Soft Tissue Sarcoma New Protocol: Regorafenib Maintenance for Sarcoma Ulas D. Bayraktar, MD 2025-04-22
Non-Small Cell Lung Cancer New Reference: Taletrectinib for ROS1-Positive NSCLC Ulas D. Bayraktar, MD 2025-04-22
GastroEsophageal Cancer New Reference: NOTCH1 Mutation as a Predictive Marker for Tislelizumab Ulas D. Bayraktar, MD 2025-04-22
